(Q33859280)

29 July 2017

1 reference

title

From Halsted to prevention and beyond: advances in the management of breast cancer during the twentieth century (English)

1 reference

29 July 2017

1 reference

1 reference

Fisher B

1

1 reference

29 July 2017

publication date

1 December 1999

1 reference

European Journal of Cancer

29 July 2017

published in

1 reference

29 July 2017

volume

35

1 reference

29 July 2017

issue

14

1 reference

29 July 2017

page(s)

1963-1973

1 reference

I. The Results of Radical Operations for the Cure of Carcinoma of the Breast

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

STREPTOMYCIN treatment of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Sixth annual Wendell G. Scott Memorial lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Kinetics of mammary tumor cell growth and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Effect of anti-oestrogens on initiation of mammary cancer in the female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Tamoxifen in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Tamoxifen. Use in treatment of metastatic breast cancer refractory to combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Tamoxifen (Nolvadex) for premenopausal patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

New Perspective on Cancer of the Contralateral Breast: A Marker for Assessing Tamoxifen as a Preventive Agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

National Surgical Adjuvant Breast and Bowel Project breast cancer prevention trial: a reflective commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900217-8

7 January 2021

10.1016/S0959-8049(99)00217-8

Identifiers

DOI

1 reference

29 July 2017

1 reference